IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON α2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS

被引：0
|
作者：
Muir, Andrew J. [1 ]
Lawitz, Eric [2 ]
Rodriguez-Torres, Maribel
Rustgi, Vinod K. [3 ]
Hassanein, Tarek [4 ]
Appleman, James R. [5 ]
Crowley, Constance A. [5 ]
Freddo, James L. [5 ]
McHutchison, John G. [1 ]
机构：
[1] Duke Univ, Med Ctr, DCRI, Durham, NC USA
[2] Alamo Med Res, San Antonio, TX USA
[3] Metropolitan Res, Fairfax, VA USA
[4] SCTI Res Fdn, Ctr Liver, San Clemente, CA USA
[5] Anadys Pharmaceut Inc, San Diego, CA USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1852
引用
收藏
页码：1200A / 1200A
页数：1
相关论文
共 50 条
  • [41] Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients with hepatitis C virus genotype 4
    Shiha, Gamal
    Samir, Waleed
    Seif, Seham
    El-Etreby, Shahira A.
    Abdel-Khalek, Ehab
    HEPATOLOGY, 2012, 56 : 1023A - 1023A
  • [42] Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load
    Neukam, Karin
    Camacho, Angela
    Caruz, Antonio
    Rallon, Norma
    Torres-Cornejo, Almudena
    Rockstroh, Juergen K.
    Macias, Juan
    Rivero, Antonio
    Benito, Jose M.
    Lopez-Cortes, Luis F.
    Nattermann, Jacob
    Gomez-Mateos, Jesus
    Soriano, Vicente
    Pineda, Juan A.
    JOURNAL OF HEPATOLOGY, 2012, 56 (04) : 788 - 794
  • [43] ASSOCIATION OF IL28B GENE VARIATIONS WITH MATHEMATICAL MODELING OF VIRAL KINETICS IN CHRONIC HEPATITIS C PATIENTS WITH PEGYLATED INTERFERON PLUS RIBAVIRIN THERAPY
    Hsu, Ching-Sheng
    Hsu, Shih-Jer
    Liu, Chen-Hua
    Liu, Chun-Jen
    Kao, Jia-Horng
    HEPATOLOGY, 2010, 52 (04) : 759A - 759A
  • [44] Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic genotype1 HCV: SILEN-C1 trial
    Sulkowski, Mark S.
    Asselah, Tarik
    Lalezari, Jacob
    Ferenci, Peter
    Fainboim, Hugo
    Leggett, Barbara
    Bessone, Fernando
    Mauss, Stefan
    Heo, Jeong
    Datsenko, Yakov
    Stern, Jerry O.
    Kukolj, George
    Scherer, Joseph
    Nehmiz, Gerhard
    Steinmann, Gerhard G.
    Boecher, Wulf O.
    HEPATOLOGY, 2013, 57 (06) : 2143 - 2154
  • [45] IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients
    Rosso, Chiara
    Abate, Maria Lorena
    Ciancio, Alessia
    Strona, Silvia
    Caviglia, Gian Paolo
    Olivero, Antonella
    Touscoz, Giovanni Antonio
    Rizzetto, Mario
    Pellicano, Rinaldo
    Smedile, Antonina
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (36) : 13146 - 13152
  • [46] IL28B polymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients
    Chiara Rosso
    Maria Lorena Abate
    Alessia Ciancio
    Silvia Strona
    Gian Paolo Caviglia
    Antonella Olivero
    Giovanni Antonio Touscoz
    Mario Rizzetto
    Rinaldo Pellicano
    Antonina Smedile
    World Journal of Gastroenterology, 2014, (36) : 13146 - 13152
  • [47] Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin
    Lange, Christian M.
    von Wagner, Michael
    Bojunga, Joerg
    Berg, Thomas
    Farnik, Harald
    Hassler, Angela
    Sarrazin, Christoph
    Herrmann, Eva
    Zeuzem, Stefan
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (11) : 1303 - 1307
  • [48] Pharmacodynamic analysis of the antiviral activity of the non-nucleoside polymerase inhibitor, HCV-796, in combination with pegylated interferon Alfa-2b in treatment-naiVe patients with chronic HCV
    Maller, Eric S.
    Raible, Donald
    Chandra, Priya
    Harper, Dawn
    Speth, John
    Shaw, Paula
    Bichier, Geraldine
    Villano, Stephen
    GASTROENTEROLOGY, 2007, 132 (04) : A740 - A740
  • [49] INTERFERON α-2B BY CONTINUOUS SUBCUTANEOUS INFUSION IN COMBINATION WITH RIBAVIRIN FOR TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS: 12 WEEK INTERIM ANALYSIS
    Muir, Andrew J.
    Bacon, Bruce R.
    Gitlin, Norman
    Kugelmas, Marcelo
    Tillman, Hans L.
    Grovender, Eric A.
    Van Antwerp, Bill
    Mische, Sarah
    Kwo, Paul Y.
    HEPATOLOGY, 2011, 54 : 1439A - 1439A
  • [50] IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study
    Mangia, Alessandra
    De Ledinghen, Victor
    Bailly, Francois
    Brahm, Javier
    Keiss, Jazeps
    Valantinas, Jonas
    Rasmann, Nele
    Messinger, Diethelm
    Tatsch, Fernando
    Bakalos, Georgios
    Foster, Graham R.
    SPRINGERPLUS, 2016, 5
12345